Gilead Sciences (Nasdaq: GILD) reported flat revenues for the first quarter of 2025, with total sales reaching $6.7 billion, ...

The US Food and Drug Administration (FDA) approved penpulimab-kcqx, from little known Chinese biotech Akeso Biopharma (HKEX: ...

Swiss-American biotech Granite Bio has exited stealth mode with $100 million in funding and plans to advance two experimental ...

Misalignment doesn't usually announce itself. It tends to show up quietly—when teams are making different assumptions, when ...

US biotech Equillium’s (Nasdaq EQ) shares fell by 3% to $0.47 after the company announced that the US Food and Drug Administration (FDA) declined to grant Breakthrough Therapy designation or support ...

Dutch biotech Avidicure has launched with $50 million in seed financing to support development of a novel class of ...

South Korea’s Samsung Bioepis today released its Second Quarter 2025 Biosimilar Market Report, which provides the second ...

Zurich-based biotech MetrioPharm has appointed Stephan Rietiker as chair of its board of directors, following a unanimous ...

US biotech Grove Biopharma has secured $30 million in a series A round to move its lead program targeting advanced prostate ...

US biopharma Novavax (Nasdaq: NVAX) closed 20% higher on Wednesday after announcing an update on its COVID-19 vaccine. The US ...

French pharma major Sanofi delivered a set of first-quarter financial results that seemed to satisfy markets Thursday, as its ...

Denmark’s Zealand Pharma (CPH: ZEAL), a company focused on the discovery and development of innovative peptide-based ...